Jian Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jian Liu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Arie Gruzman
Bioconformatics Laboratory and Department of Neuroscience, California Pacific Medical Center Research Institute, San Francisco, CA 94107, USA
1 shared publication- Don W. Cleveland
Department of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, USA
1 shared publication Evgenia Alpert
Bioconformatics Laboratory and
1 shared publicationJeffery D. Rothstein
Department of Neurology, Johns Hopkins University, Baltimore, MD 21287
1 shared publicationM. Dharma Prasad
Bioconformatics Laboratory and
1 shared publicationRobert Bowser
Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
1 shared publication
Latest Publications
- 24 July 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (30) , 12524-12529
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron degenerative disease whose etiology and pathogenesis remain poorly understood. Most cases of ALS (≈90%) are sporadic (SALS), occurring in the absence of genetic associations. Approximately 20% of familial ALS (FALS) cases are due to known mutations in the copper, zinc superoxide dismutase (SOD1) gene. Molecular evidence for a common pathogenesis of SALS and FALS has remained elusive. Here we use covalent chemical modification to reveal an attribute of spinal cord SOD1 common to both SOD1-linked FALS and SALS, but not present in normal or disease-affected tissues from other neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases and spinal muscular atrophy, a non-ALS motor neuron disease. Biotinylation reveals a 32-kDa, covalently cross-linked SOD1-containing protein species produced not only in FALS caused by SOD1 mutation, but also in SALS. These studies use chemical modification as a novel tool for the detection of a disease-associated biomarker. Our results identify a shared molecular event involving a known target gene and suggest a common step in the pathogenesis between SALS and FALS.
- 24 July 2007
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 104 (30) , 12524-12529
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron degenerative disease whose etiology and pathogenesis remain poorly understood. Most cases of ALS (≈90%) are sporadic (SALS), occurring in the absence of genetic associations. Approximately 20% of familial ALS (FALS) cases are due to known mutations in the copper, zinc superoxide dismutase (SOD1) gene. Molecular evidence for a common pathogenesis of SALS and FALS has remained elusive. Here we use covalent chemical modification to reveal an attribute of spinal cord SOD1 common to both SOD1-linked FALS and SALS, but not present in normal or disease-affected tissues from other neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's diseases and spinal muscular atrophy, a non-ALS motor neuron disease. Biotinylation reveals a 32-kDa, covalently cross-linked SOD1-containing protein species produced not only in FALS caused by SOD1 mutation, but also in SALS. These studies use chemical modification as a novel tool for the detection of a disease-associated biomarker. Our results identify a shared molecular event involving a known target gene and suggest a common step in the pathogenesis between SALS and FALS.